We have a full fledged QCQA department at our Daman Plant & Research & Development department under the guidance of our parent Company M/s Aristo Pharma at Mandideep. The R&D wing & Analytical research & development section is recognized by the department of Science & Technology, Govt. of India.
Marketing efforts of Mapra are supported by a strong Team of highly qualified analytical & formulations Technical experts. Both our plants are equipped with State-of-the-Art technology & equipments facilitating development of conventional & novel drug delivery systems complying to highest standards of quality.
Our capabilities of drug product development are
Immediate release tablets
Enteric coated tablets
Delayed release tablets
Mouth dissolving tablets
Extended release tablets
Dry powder for oral suspension
Oral liquid suspension/ syrups
Hard gelatin capsules
Multiple units delayed release/ Extended release tablets (MUPS)
Topical gels, creams, ointments
Powder for injections
The analytical research & development and QC & QA departments supports all the developmental work of formulation development. We are well equipped with sophisticated instruments capable of stability studies, validation & method or process transfer.
New product development, new process development & ultimate International Quality in offering the best in the clinical application to our end users is our endeavour.